Letters
Coronary artery disease: screen or treat?
Authors’ reply to Perry
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2031 (Published 12 April 2016) Cite this as: BMJ 2016;353:i2031
- Darrel P Francis, professor1,
- Graham D Cole, specialty registrar1
- 1International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London W2 1LA, UK
- d.francis{at}imperial.ac.uk
We thank Perry for raising the interesting difference between research trials where both patients and staff are blinded to whether the tablet is really a statin and everyday practice where patients and doctors know whether a statin is being taken.1 2 In the blinded trials, there …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.